معرفی
Dr. Ayesha Fawad is a Postdoctoral Fellow at Lund University's Clinical Memory Research unit and MultiPark (Multidisciplinary Research focused on Parkinson's Disease), with additional affiliation to the Translational Diabetes Research unit. As a General Medicine specialist practicing clinically in Sweden since 2010, she contributes to the LU Profile Area: Proactive Ageing.
Her research centers on early identification of health vulnerabilities using dual biological and social markers, with particular focus on Alzheimer's disease preclinical detection in primary care (Swedish BioFINDER Primary Care study) and proneurotensin's role in cardiometabolic diseases. Key areas include biomarker validation, cardiometabolic risk stratification, and cross-cultural health disparities in diabetes.
Current research trends reveal strong emphasis on proneurotensin as a multifunctional biomarker across 5 major publications (2019-2022), connecting lipid metabolism, glucose regulation, and mortality prediction. Her work demonstrates methodological diversity spanning randomized controlled trials, longitudinal cohort analyses, and cross-cultural epidemiological studies.
Dr. Fawad leads and participates in three active research projects:
- Cognition and Functional Decline in Primary Care (Greta and Johan Kock Foundation, 2025-2026) as Principal Investigator
- Recognition and referral of cognitive impairment in primary care (2023-present) as Researcher
- EDAP: Early diagnostics and prognostics of Alzheimer’s disease (2023-present) as Researcher
She operates within Lund University's Clinical Memory Research unit and the MultiPark consortium, leveraging multidisciplinary collaborations across neurology, endocrinology, and primary care research infrastructure to advance early diagnostic methodologies for neurodegenerative and metabolic diseases.
